entered into a research agreement with XOMA
to optimize an antibody. The partnership will leverage Zymeworks’ ZymeCAD
™ suite of predictive protein engineering tools and XOMA’s Targeted Affinity Enhancement
ZymeCAD molecular simulation platform creates a modeling environment that generates novel physical and chemical insights into protein systems, according to Zymeworks.